Lataa...

Targeted Therapies for Melanoma Brain Metastases

Brain metastases are a major clinical challenge occurring in up to 60% of patients suffering from metastatic melanoma. They cause significant clinical symptoms and impair the overall survival prognosis. The introduction of targeted therapies including BRAF and MEK inhibitors as well as CTLA-4 and PD...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:Curr Treat Options Neurol
Päätekijät: Berghoff, Anna S., Preusser, Matthias
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: Springer US 2017
Aiheet:
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC5378732/
https://ncbi.nlm.nih.gov/pubmed/28374234
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s11940-017-0449-2
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!